1.Clinical Efficacy of Salmeterol and Fluticasone Propionate Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease
China Pharmacy 2007;0(28):-
OBJECTIVE:To observe clinical efficacy of salmeterol and fluticasone propinate inhalation in the treatment of chronic obstructive pulmonary disease (COPD).METHODS:348 patients were randomly diuided into trial group(n=180) and control group(n=168).Both groups received comprehensive treatment for 15 days.Trial group additionally received one time of seretide inhalation twice a day.RESULTS:The clinical symptoms and the improvement of lung function in trial group were superior to in control group obviously.CONCLUSION:Salmeterol and fluticasone propinate inhalation can be applicable to treat COPD and have an ideal assistant effect.
2.Serum miR-103 as a potential diagnostic biomarker for breast cancer.
Xiaopai WANG ; Xingping WU ; Lixu YAN ; Jianyong SHAO
Journal of Southern Medical University 2012;32(5):631-634
OBJECTIVETo evaluate the diagnostic value of serum miR-103 for breast cancer and its correlation to the clinicopathological features of the patients.
METHODSWe collected the serum samples and corresponding formalin-fixed paraffin-embedded (FFPE) surgical specimens from 50 breast cancer patients, using the serum samples from 50 healthy women as the control. The total RNA was extracted from the samples for quantitative analysis of miR-103 using real-time RT-PCR.
RESULTSThe serum levels of miR-103 expression were significantly higher in the cancer patients than in the healthy control group (P<0.01). In the cancer patients, high miR-103 expression was significantly correlated to advanced clinical stage (P<0.05) and lymph node metastasis (P<0.05). miR-103 showed a receiver operating characteristic (ROC) curve area of 84.3%, and a sensitivity of 84% and a specificity of 70% in discriminating breast cancer patients from the control subjects.
CONCLUSIONSerum miR-103 can serve as a potential diagnostic marker for breast cancer and provides useful information of the clinicopathological features of the patients.
Adult ; Aged ; Biomarkers, Tumor ; blood ; Breast Neoplasms ; diagnosis ; Case-Control Studies ; Female ; Humans ; MicroRNAs ; blood ; Middle Aged ; Sensitivity and Specificity
3.Morbidity and outcome of post-stroke Holmes tremor
Fei GAO ; Lixu LIU ; Yudong CHEN ; Yuqi YANG ; Hanzhi LI ; Xueyan HU ; Lei SHAN ; Xiaoli WU ; Changqing YE
Chinese Journal of Rehabilitation Theory and Practice 2022;28(1):50-54
Objective To investigate the incidence of Holmes tremor (HT) after stroke and its outcome after medication and rehabilitation. Methods Patients diagnosed as HT after stroke in the ward of neurorehabilitation department from October, 2019 to September, 2021 were reviewed the clinical features, imaging manifestations, drug treatment plan, rehabilitation evaluation scales scores, rehabilitation plan and outcome. Results There were five inpatients with HT (0.7%, 5/715), and all were hemorrhagic stroke, accounting for 1.7% of hemorrhagic stroke. The lesions were located in the midbrain and pons in three cases, cerebellum in one case and thalamus in one case. The tremor appeared 1.5 to seven months after stroke, limited on head and limbs, with other neurological dysfunction. After the comprehensive treatment of drugs and rehabilitation, tremor improved in four cases, and ineffective in one case. The motor and balance function improved less, and the activities of daily living improved somehow. Conclusion The incidence of Holmes tremor is low in stroke patients. The tremor might respond to the treatment, but motor function would not.
4.Epidemiology and functional outcome of venous thromboembolism after stroke in rehabilitation wards
Xiaoli WU ; Xueyan HU ; Yuge ZHANG ; Changqing YE ; Yudong CHEN ; Hanzhi LI ; Lingyu YANG ; Fei GAO ; Yuqi YANG ; Lei SHAN ; Lixu LIU
Chinese Journal of Rehabilitation Theory and Practice 2022;28(1):44-49
Objective To explore the risk of venous thromboembolism (VTE), especially lower-extremity deep vein thrombosis (DVT) and pulmonary embolism (PE), for stroke patients in rehabilitating, and the functional outcome. Methods A total of 3 557 stroke patients in the neurological rehabilitation center of Beijing Bo'ai Hospital for stroke rehabilitation from January, 2015 to October, 2020 were reviewed through the electronic medical record system. Demographic characteristics, stroke characteristics (type and location), laboratory data (D-dimer polymer and arterial partial pressure of oxygen), motor function (Brunnstrom stage, Fugl-Meyer Assessment of motor and balance, modified Ashworth Scale score of triceps crus, and Holden Walking Ability Classification), activities of daily living (Barthel Index), and anticoagulant/antiplatelet treatment data were collected and analyzed. Results The incidence of DVT and PE was 28.5% and 1.29%, respectively. Most were found 30 days later after onset. The incidence of PE was higher after ischemic stroke (χ2 = 12.49, P < 0.001) rather than hemorrhagic stroke. The patients with hemispheric stroke, severe lower-extremity paralysis, and poor activities of daily living were more prone to complications associated with VTE. After rehabilitation, the function of stroke patients with PE could be improved (|t| > 4.302, P < 0.001). Conclusion The risk of DVT and PE in patients during stroke convalescence may not be negligible, and those with older age, previous history of thrombosis, severe stroke, and severe limb paralysis may be stratified in high-risk. Following anticoagulation treatment, early individualized comprehensive rehabilitation can be done for patients with PE to improve their function and activities of daily living.